Background: Iron accumulation in the central nervous system (CNS) is a common feature of many neurodegenerative
Introduction
Iron is a redox active metal that can exist in the ferrous or ferric state, and it plays an important role in many metabolic functions (1) . However, ferrous iron can generate toxic free radicals that can damage proteins, lipids, and DNA (2, 3) . A complex interplay between multiple iron-binding proteins, transporters, ferroxidases, ferrireductases, receptors, and regulatory systems permits the safe handling of iron in the body (4, 5) . Disruption of this finely tuned system can result in iron accumulation or iron deficiency and associated adverse effects (2, 6) .
Iron plays important functional roles in the brain. Although widely distributed, there are iron-rich brain regions and celltype-specific (7) differences in iron levels. Iron accumulation in specific regions of the brain is a key feature of both aging (8, 9) and multiple neurodegenerative diseases, such as AlzheimerÕs disease, ParkinsonÕs disease, amyotrophic lateral sclerosis, multiple sclerosis, HuntingtonÕs disease, aceruloplasminemia, and others (10) (11) (12) . Several cell types, including oligodendrocytes, astrocytes, and microglia, likely play important roles in iron metabolism in the brain (13) . However, an understanding of iron homeostasis in the brain has lagged behind that of systemic iron metabolism (2, 8) , and the mechanisms underlying both normal iron homeostasis and pathologic iron accumulation in the central nervous system (CNS) 9 need to be clarified (2, 8) .
Iron export from cells is a key process in systemic, tissue, and individual cellular iron homeostasis. Two key components, the ubiquitously expressed ferrous iron (Fe 2+ ) membrane transporter, ferroportin 1 (FPN1), and a multicopper ferroxidase (MCF), mediate cellular iron export. Our current understanding indicates that MCFs on the cell surface oxidize Fe 2+ to ferric state (Fe 3+ ), facilitating iron release from FPN1 (14) . There are 3 known mammalian MCF proteins: ceruloplasmin (CP), hephaestin (HEPH), and the recently discovered zyklopen (15) (16) (17) .
Previous studies in mice and humans have demonstrated that MCF gene disruption leads to cell-type-specific iron accumulation and neurologic defects (18) (19) (20) . Sex-linked anemia (sla) mice contain an in-frame deletion of Heph that results in substantially decreased ferroxidase activity (although measurable activity remains) (16, 21, 22) . These animals exhibit iron accumulation in gray matter (but not white matter) oligodendrocytes by 2-3 mo of age and show motor deficits by 6 mo of age (19) . In contrast, mice lacking CP accumulate iron in astrocytes by 18 mo of age (18) . Disruption of Cp and Heph together (in Cp-null sla mutant mice) leads to iron accumulation in white matter oligodendrocytes and retinal pigment epithelial cells (19, 20) . In humans, mutations in the Cp gene that result in loss of functional CP (aceruloplasminemia) lead to iron accumulation and neurodegeneration, particularly in the motor regions of the brain and in the retina (15, 23, 24) . The effect of mutations in Heph in humans has not been reported, but a single nucleotide polymorphism in the 5# untranslated region of the Heph gene has been linked to a hereditary form of migraine (25) . Recently, we generated a global hephaestin knockout (Heph KO) mouse, which lacks the residual ferroxidase activity observed in the sla mouse (26) . In this study, we seek to clarify the role of MCFs in CNS iron metabolism by analyzing and comparing the effects of Heph KO and Cp KO in brain iron homeostasis.
Methods
Mice. Heph KO, Cp KO, and wild-type (WT) mouse strains were originally obtained from the laboratory of Gregory Anderson (Berghofer Medical Research Institute) and were then bred and maintained at the Medical School of Nanjing University. The Heph KO mice were generated in the laboratory of Chris Vulpe (University of California, Berkeley) by germline knockout via the cre-lox system (26) using mice with a floxed Heph allele (Heph tm1.1Jdun ) obtained from the laboratory of Joshua Dunaief (University of Pennsylvania) (20) . Cp KO mice (Cp tm1Hrs ) (27) were originally generated by Leah Harris (Northwestern University). All mice were on the C57BL/6J genetic background. The mice were allowed unlimited access to a standard rodent unpurified diet (28) provided by Jiangsu Province Collaborative Medical Bioengineering Co., Ltd. All mouse protocols were in accordance with the NIH guidelines, as described in the Guide for the Care and Use of Laboratory Animals of the NIH, and were approved by the Institutional Animal Care and Use Committee of Nanjing University.
Tissue preparation. Male mice from each litter were killed at 4 or 8 wk or 6-7 mo of age after anesthesia. Blood was collected by cardiac puncture and then brain regions were either quickly dissected on ice for mRNA quantification analysis, or, for protein and iron concentration analysis, the body was perfused with PBS via the heart. Brain regions were excised and stored immediately. Liver and spleen were removed, and sera and enterocytes were isolated as previously described (29) . All samples were snap frozen in liquid nitrogen immediately after collection and then stored at 280°C for subsequent RNA, protein, and iron concentration analysis.
Iron measurement. The iron concentration of tissues was measured using an Atomic Absorption Spectrometer (180-80, Hitachi; Japan) at the Modern Instrumental Analysis Center of Nanjing University following the nitric acid digestion method (29) .
Tissue genotyping by semiquantitative PCR. DNA was prepared from fresh tail tip samples using the HOTSHOT method (30) . PCR was performed using GoTaq Hot Start Green master mix (Promega) as per the manufacturerÕs instructions. Primers, annealing temperatures, and expected product sizes are as previously described (26) .
Total RNA extraction and qRT-PCR analysis. Total RNA was isolated from mouse tissues using TRIzol reagent (Invitrogen) according to the manufacturerÕs protocol. Three micrograms of total RNA were reverse transcribed. qRT-PCR was used to measure the expression of divalent metal transporter 1 (Dmt1), Dmt1 with ironresponsive element (Dmt1+IRE), Dmt1 without IRE (Dmt12IRE), Fpn1, Heph, Cp, and transferrin receptor 1 (Tfrc) in different regions of the brain. All primers (Supplemental Table 1 ) were designed by Primer3 software using the default settings (31) . Expression levels were normalized to that of the housekeeping genes GAPDH or hypoxanthine phosphoribosyltransferase (HPRT) (32, 33) . Two-step PCR was monitored in real time by the FastStart Universal SYBR-Green Master (Roche Applied Science) according to the manufacturerÕs instructions on an Applied Biosystems 7300 Real-Time PCR System instrument (Life Technologies).
Immunoblot analysis. Mouse brain regions from 6-to 7-mo-old WT, Heph KO, and Cp KO mice (n = 10-20 per genotype) were homogenized in homogenization buffer: 13 PBS, 1% Triton X-100, 0.1% SDS, and protease inhibitor cocktail. Enterocytes were lysed as described (29) . The total protein concentration was determined by the Bio-Rad protein assay. For all studies, samples containing 20-100 mg of protein were denatured by boiling for 5 min in 23 SDS sample buffer. The proteins were separated by SDS-PAGE (6% acrylamide running gel) and transferred to nitrocellulose membranes. Blots were first incubated for 1 h with blocking buffer (0.1% PBS-Tween and 10% nonfat dry milk), and then incubated with primary antibodies overnight at 4°C. The following primary antibodies were used: HEPH (HEPH antibody; 1:1000) (34), L-ferritin (1:1000; catalogue no. sc-74513, Santa Cruz Biotech), and b-tubulin (1:5000; catalogue no. M20005, Abmart). Blots were then washed 3 times in 0.1% PBS-Tween, incubated for 1 h at room temperature with 1:2000 or 1: 40,000 diluted peroxidase-labeled antimouse or anti-rabbit secondary antibodies (catalogue no. sc-2031 or sc-2030, Santa Cruz Biotech), and signals were visualized by enhanced chemiluminescence (Thermo Scientific).
Statistical analysis. Unless otherwise indicated, values are means 6 SEMs. One-factor ANOVA with TukeyÕs test for multiple comparisons was used to compare means for mouse tissue iron concentrations (i.e., cortex, hippocampus, brainstem, cerebellum, liver, spleen, enterocytes, and serum) and protein levels (i.e., L-ferritin and HEPH) among 3 groups. One-factor ANOVA with DunnettÕs test for multiple comparisons was used to compare means for gene expression (i.e., Dmt1+IRE, Dmt12IRE, Fpn1, Heph, Cp, and Tfrc) with control WT. If data were found to have unequal variances, they were log transformed. Differences were considered statistically significant at P < 0.05. All statistical analyses were performed using Prism 6 Software (GraphPad).
Results
Verification of Heph KO and Cp KO gene. Genetic deletion of Heph and Cp throughout the brain was verified by semiquantitative PCR genotyping of DNA from knockout mice and WT control littermates. As expected, knockout of Heph and knockout of Cp were observed in all Heph KO and Cp KO tissues examined, respectively, and only WT alleles were present in WT control tissues (data not shown).
Iron concentrations of different brain regions and other tissues in knockout and WT mice. We measured iron concentrations in the brain and other selected tissues of Heph KO, Cp KO, and WT control mice at 3 different ages. In young mice at 4 and 8 wk of age (Supplemental Table 2 ), the iron concentrations in the brain regions examined did not differ significantly (P > 0.05). However, at 6-7 mo of age (Figure 1) , the iron concentrations were significantly higher in the cortex (30% greater; P < 0.05), hippocampus (80% greater; P < 0.05), brainstem (20% greater; P < 0.05), and cerebellum (20% greater; P < 0.05) in Heph KO mice than in WT and Cp KO mice.
Iron concentrations in non-CNS tissues of mice were also measured at 4 and 8 wk of age (Supplemental Table 3 ) and at 6-7 mo of age ( Table 1) . At 4 wk of age, Heph KO mice had significantly less (P < 0.05) iron than WT and Cp KO mice in their heart, liver, spleen, and kidney except in enterocytes, where the concentration was significantly higher (P < 0.05). Cp KO mice at that age had a higher (P < 0.05) concentration of iron in their liver, spleen, and kidney, but serum iron concentrations for all 3 mouse genotypes were not significantly different (P = 0.40). At 8 wk and 6-7 mo of age, the concentration of iron in the liver and spleen remained significantly lower (P < 0.05) in the Heph KO mice than in the WT control and Cp KO groups, and liver iron was significantly greater (P < 0.05) in the Cp KO mice than in WT controls and Heph KO mice. Iron concentration in enterocytes was higher in the Heph KO and Cp KO mice than in WT control mice but these changes were not statistically different (8 wk: P = 0.07; 6-7 mo: P = 0.06). At 6-7 mo of age, the serum iron concentration in Cp KO mice was significantly lower (P < 0.05) than in the WT control and Heph KO groups. The non-CNS tissue iron quantitative data support a persistent systemic iron deficiency in mice with Heph dysfunction or ablation as previously noted (26, 29, 35) .
Change of ferritin and HEPH protein levels in CNS regions. A significantly higher level of ferritin protein was observed in the cortex (200% greater; P < 0.05), hippocampus (300% greater; P < 0.05), brainstem (150% greater; P < 0.05), and cerebellum (100% greater; P < 0.05) of Heph KO mice than in Cp KO mice and WT controls at 6-7 mo of age (Figure 2A-H) . Furthermore, HEPH protein levels were assessed by Western blot analysis of the cortex, hippocampus, brainstem, and cerebellum in all 3 genotypes at 6-7 mo of age (Figure 2A-D) . As expected, we found no HEPH protein expression in Heph KO mice. HEPH protein levels, however, were significantly increased in Cp KO hippocampus (80% greater; P < 0.05) and cerebellum (150% greater; P < 0.05) than in WT ( Figure 2J, L) , but no differences were detected in the cortex (P = 0.71) or brainstem (P = 0.82; Figure 2I , K).
Expression of Heph, Cp, and iron transporters in WT and MCF knockout mice. The expression of Dmt1, Fpn1, Heph, Cp, and Tfrc mRNA in a panel of 11 different brain regions, including the olfactory bulb, cortex, striatum, hippocampus, hypothalamus, substantia nigra, brainstem (midbrain, pons, and medulla), cerebellum, and spinal cord, of WT mice at 6 mo of age was examined by qRT-PCR (Figure 3) . We showed that Dmt1 is widely expressed in the WT brain and has higher expression in the hypothalamus, substantia nigra, and cerebellum than in the striatum, pons, and medulla (160-190% greater; jn.nutrition.org P < 0.05; Figure 3A ). The Fpn1 gene is widely expressed with higher expression in the olfactory, midbrain, pons, and medulla than in the cerebellum (60-70% greater; P < 0.05; Figure 3B ). Heph expression is higher in the midbrain, pons, and medulla than in the olfactory, cortex, striatum, substantia nigra, and cerebellum (90-220% greater; P < 0.05), and Cp expression is greater in the cerebellum and spinal cord than in the olfactory and substantia nigra (100-160% greater; P < 0.05; Figure 3C , D). Figure 3E shows that Tfrc is also widely expressed, with higher relative expression in the midbrain than in the olfactory, cortex, striatum, and hypothalamus (140-200% greater; P < 0.05).
The mRNA expression of these 5 iron metabolism genes was further examined by qRT-PCR in the cortex, hippocampus, brainstem, and cerebellum of Heph KO, Cp KO, and WT mice at 6 mo of age (Figure 4 ). Dmt1+IRE and Fpn1 mRNA expression were significantly decreased whereas Tfrc mRNA expression was significantly increased in Heph KO (Dmt1+IRE: 40% less, P < 0.01; Fpn1: 50% less, P < 0.05; Tfrc: 30% greater, P < 0.05) and Cp KO (Dmt1+IRE: 40% less, P < 0.01; Fpn1:
60% less, P < 0.01; Tfrc: 60% greater, P < 0.05) mouse hippocampus than in WT controls ( Figure 4A, B, F) . Tfrc mRNA levels were also significantly increased in Cp KO mouse cortex (60% greater; P < 0.01) than in WT controls ( Figure 4F ), and Dmt1+IRE mRNA was significantly decreased in the cerebellum (50% less; P < 0.05) of Heph KO mice than in WT controls ( Figure 4A ). However, expression of the Dmt12IRE for all 3 mouse genotypes was not significantly different in the cortex (Heph KO: P = 0.99; Cp KO: P = 0.99), hippocampus (Heph KO: P = 0.94; Cp KO: P = 0.84), brainstem (Heph KO: P = 0.94; Cp KO: P = 0.60), and cerebellum (Heph KO: P = 0.19; Cp KO: P = 0.48; Figure 4B ). Interestingly, Heph mRNA was significantly increased in the cortex (100% greater; P < 0.01), hippocampus (350% greater; P < 0.001), brainstem (30% greater; P < 0.01), and cerebellum (150% greater; P < 0.001) in Cp KO mice ( Figure 4D ). Cp expression, however, was not significantly increased by Heph KO in the cortex (P = 0.57), brainstem (P = 0.78), and cerebellum (P = 0.08) but was significantly decreased in the hippocampus (20% less; P < 0.05) of Heph KO mice than in WT controls ( Figure 4E ).
Discussion
We examined tissue iron levels in various brain regions and multiple non-CNS tissues of Heph KO, Cp KO, and WT control mice at several ages. Previous studies found that juvenile Heph KO and sla mice exhibit low tissue iron levels and anemia that gradually improve with age (22, 26, (35) (36) (37) . Similarly, we found iron deficiency in Heph KO mice at 4 wk of age and persistently low iron levels in the liver and spleen at 8 wk and 6-7 mo of age. Despite systemic iron deficiency, brain iron levels of Heph KO mice were not different from WT at 4 and 8 wk of age (Supplemental Table 2 ). In fact, at 6-7 mo of age, Heph KO mice demonstrated iron accumulation in the cortex, hippocampus, brainstem, and cerebellum and 3 Value tended to be greater in Heph KO than in WT and Cp KO (P = 0.06).
FIGURE 2
Ferritin and HEPH protein levels in the cortex (A, E, I), hippocampus (B, F, J), brainstem (C, G, K), and cerebellum (D, H, L) of WT, Heph KO, and Cp KO mice at 6-7 mo of age. Levels of ferritin and HEPH protein were normalized to tubulin. Values are means 6 SEMs, n = 5-7. Within each panel, bars without common letters differ, P , 0.05. Cp KO, global ceruloplasmin knockout; HEPH, hephaestin; Heph KO, global hephaestin knockout; WT, wild type.
concomitantly increased ferritin levels, suggesting that iron accumulates with age in brain regions in Heph KO mice. Increased iron in the spinal cord with age was reported previously in sla mice (19) .
In contrast to Heph KO mice, Cp KO mice have been previously reported to have increased spleen and liver iron and, in some studies, decreased serum iron at 10-12 wk (38) and 1 y of age (18, 35) . In agreement, Cp KO mice had similar or higher levels of iron in their non-CNS tissues at 4 and 8 wk of age compared with WT (Supplemental Table 3 ). At 6-7 mo of age, Cp KO mice had higher iron levels in the liver and spleen but lower serum iron concentration than WT or Heph KO mice. Like Heph KO mice, Cp KO mice had similar levels of iron compared with WT mice in the brain regions examined at 4 and 8 wk of age. In contrast to Heph KO mice, Cp KO brain regions did not show iron accumulation or ferritin protein level changes at 6-7 mo of age when compared with WT. Previous work showed brain iron accumulation at 12 mo of age in Cp KO mice that increases with age (18) , so iron loading may occur later than in Heph KO mice. A gradual age-dependent iron accumulation in the CNS of mice and people lacking CP has been proposed to contribute to neurodegeneration in aceruloplasminemia (15, 18, 24) . Together, these results indicate that both HEPH and CP play important roles in maintaining brain iron homeostasis.
Most cells in the body express a full complement of iron proteins, including TFRC and DMT1 for iron uptake, and the iron exporter FPN1 (13, 39) , often in conjunction with expression of a ferroxidase. Our results suggest that Dmt1, Fpn1, Heph, Cp, and Tfrc mRNA are expressed widely in various brain regions of WT mice.
Our expression studies indicate that the loss of Heph or Cp perturbs the expression of the other ferroxidase gene. We noted increased expression of Heph mRNA in multiple Cp KO mice brain regions including the cortex, hippocampus, cerebellum, and brainstem. Also, HEPH protein expression was increased in the Cp KO mice brain regions of the hippocampus and cerebellum. Alterations in Heph expression in the brain of Cp KO mice could represent a compensatory response to alterations in brain iron metabolism. We speculate that increased expression of Heph may preserve some iron efflux in Cp KO mice and may explain the late onset of iron overload in the CNS of Cp KO mice (after 18 mo of age) (18) . Previous work found that mice with the mutant Heph sla mutation and lacking Cp, but not mice with only the sla mutation or the Cp KO alone, have retinal iron overload by 3-6 mo of age (40) . Similarly, Heph sla/Cp double mutant mice unlike the sla mutant show robust iron accumulation in white and gray matter oligodendrocytes in the spinal cord (19) . An alternatively spliced, glycosylphosphatidylinositol (GPI)-anchored form of CP is expressed by astrocytes and is the major form of CP in the CNS (41, 42) . The liver also produces a secreted form of CP that is abundant in serum but does not cross the blood-brain barrier (43) . The GPI-CP is associated with the iron exporter FPN1 on the cell surface and is required for iron efflux from astrocytes in vitro (44) . Because HEPH is a membrane-bound ferroxidase that partners with FPN1 to facilitate iron export, it may partially compensate for loss of the GPI-CP form (44) . However, we did not find evidence of CP compensation for HP loss, in contrast to previous findings that found increased CP protein expression in the white matter of sla spinal cord oligodendrocytes (19) . Cp expression was not increased in brain regions of the Heph KO mice, although the spinal cord was not examined in the current work. In fact, Cp mRNA expression was significantly lower in Heph KO mouse hippocampus than in WT controls. Together, these results Deficiency of either ferroxidase resulted in iron accumulation and changes in iron metabolism genes, indicative of perturbed local iron metabolism in the hippocampus. Hippocampal Dmt1+IRE and Fpn1 mRNA expression were significantly lower, whereas iron levels, ferritin protein levels, and Tfrc mRNA levels were higher in Heph KO mice. In addition, as noted previously, Heph gene and protein expression were increased in the hippocampus of the Cp KO mice, whereas Cp gene expression was decreased in Heph KO mice. Although the increased iron and ferritin protein levels are consistent with intracellular iron accumulation in the hippocampus, the altered expression of the other genes suggests a more complex picture. Dmt1, Fpn1, and Tfrc have complex post-transcription regulation via 1 or more IREs. Tfrc mRNA levels would be expected to be decreased in cellular iron overload. However, we noted increased Tfrc mRNA levels despite the overall increased iron levels in the hippocampus. Because the hippocampus contains multiple cell types, increased iron levels in some cell types could increase ferritin levels, while simultaneously decreased iron levels in other cell types result in the observed increase in Tfrc mRNA levels. Both Heph KO mice and sla mutant mice exhibit systemic iron deficiency but local (enterocyte and gray matter oligodendrocyte) iron overloading (19, 26, 29) . We hypothesize that lack of HEPH results in defective export of iron from hippocampal oligodendrocytes and, consequently, iron overload in these cells and iron deficiency in other cell types (e.g., neuron) in the same tissue. Together, these results suggest a complex picture of disordered iron metabolism in the hippocampus with simultaneous iron deficiency and iron overload in different cell types.
Overall, our results support distinct roles for HEPH and CP in brain iron homeostasis. Further understanding of the respective roles of HEPH and CP in maintaining brain iron homeostasis could provide insight into the pathophysiology of these diseases. In particular, the early age of onset of iron accumulation in the Heph KO mice suggests that these mice may provide a novel model of neurodegenerative disorders.
